Tsuyoshi Uehara

ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 6

Top Venues

Microbiology spectrum

ACS infectious diseases

Antimicrobial agents and chemotherapy

PloS one

VenatoRx Pharmaceuticals (United States)

Tokyo Daigaku (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

VenatoRx Pharmaceuticals (United States) Dec 03 2018

United States

Principal Scientist

Novartis Institutes for BioMedical Research Dec 12 2011 - Sep 12 2018

United States

Investigator III (promoted from Investigator II, 2015 Oct) :: Infectious Diseases – Antibiotic Discovery

Harvard Medical School Sep 01 2007 - Dec 11 2011

United States

Instructor :: Microbiology and Molecular Genetics

Tufts University School of Medicine Apr 01 2000 - Aug 31 2007

United States

Postdoctoral Research associate :: Molecular Biology & Microbiology

Education History

Tokyo Daigaku Apr 01 1997 - Mar 31 2000

Japan

PHD :: Biotechnology

Tokyo Daigaku Apr 01 1991 - Mar 31 1995

Japan

BSC :: Biotechnology

Publications

James A Karlowsky, Mark G Wise, Meredith A Hackel, David A Six, Tsuyoshi Uehara, Denis M Daigle, Daniel C Pevear, Greg Moeck, Daniel F Sahm
Cefepime-taniborbactam activity against antimicrobial-resistant clinical isolates of Enterobacterales and Pseudomonas aeruginosa: GEARS global surveillance programme 2018-22. The Journal of antimicrobial chemotherapy (2024)
Michael R Jacobs, Ayman M Abdelhamed, Caryn E Good, Andrew R Mack, Christopher R Bethel, Steven Marshall, Andrea M Hujer, Kristine M Hujer, Robin Patel, David Van Duin, Vance G Fowler, Daniel D Rhoads, David A Six, Greg Moeck, Tsuyoshi Uehara, Krisztina M Papp-Wallace, Robert A Bonomo
ARGONAUT-III and -V: susceptibility of carbapenem-resistant Klebsiella pneumoniae and multidrug-resistant Pseudomonas aeruginosa to the bicyclic boronate β-lactamase inhibitor taniborbactam combined with cefepime. Antimicrobial agents and chemotherapy (2024)
Elyse J Roach, Tsuyoshi Uehara, Denis M Daigle, David A Six, Cezar M Khursigara
The Next-Generation β-Lactamase Inhibitor Taniborbactam Restores the Morphological Effects of Cefepime in KPC-Producing Escherichia coli. Microbiology spectrum 9 (2) (2021)
Wooseok Han, Xiaolei Ma, Carl J Balibar, Christopher M Baxter Rath, Bret Benton, Alun Bermingham, Fergal Casey, Barbara Chie-Leon, Min-Kyu Cho, Andreas O Frank, Alexandra Frommlet, Chi-Min Ho, Patrick S Lee, Min Li, Andreas Lingel, Sylvia Ma, Hanne Merritt, Elizabeth Ornelas, Gianfranco De Pascale, Ramadevi Prathapam, Katherine R Prosen, Dita Rasper, Alexey Ruzin, William S Sawyer, Jacob Shaul, Xiaoyu Shen, Steven Shia, Micah Steffek, Sharadha Subramanian, Jason Vo, Feng Wang, Charles Wartchow, Tsuyoshi Uehara
Two Distinct Mechanisms of Inhibition of LpxA Acyltransferase Essential for Lipopolysaccharide Biosynthesis. Journal of the American Chemical Society 142 (9) (2020)
Xiaolei Ma, Ramadevi Prathapam, Charles Wartchow, Barbara Chie-Leon, Chi-Min Ho, Javier De Vicente, Wooseok Han, Min Li, Yipin Lu, Savithri Ramurthy, Steven Shia, Micah Steffek, Tsuyoshi Uehara
Structural and Biological Basis of Small Molecule Inhibition of Escherichia coli LpxD Acyltransferase Essential for Lipopolysaccharide Biosynthesis. ACS infectious diseases 6 (6) (2019)
William S Sawyer, Lisha Wang, Tsuyoshi Uehara, Pramila Tamrakar, Ramadevi Prathapam, Mina Mostafavi, Louis E Metzger, Brian Feng, Christopher M Baxter Rath
Targeted lipopolysaccharide biosynthetic intermediate analysis with normal-phase liquid chromatography mass spectrometry. PloS one 14 (2) (2019)

Tsuyoshi Uehara.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Tsuyoshi Uehara